Ortho Evra - 50458-192-15 - (norelgestromin and ethinyl estradiol)

Alphabetical Index


Drug Information of Ortho Evra

Product NDC: 50458-192
Proprietary Name: Ortho Evra
Non Proprietary Name: norelgestromin and ethinyl estradiol
Active Ingredient(s): .75; 6    mg/7d; mg/7d & nbsp;   norelgestromin and ethinyl estradiol
Administration Route(s): TRANSDERMAL
Dosage Form(s): PATCH, EXTENDED RELEASE
Coding System: National Drug Codes(NDC)

Labeler Information of Ortho Evra

Product NDC: 50458-192
Labeler Name: Janssen Pharmaceutical, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021180
Marketing Category: NDA
Start Marketing Date: 20011120

Package Information of Ortho Evra

Package NDC: 50458-192-15
Package Description: 3 PATCH in 1 CARTON (50458-192-15) > 7 d in 1 PATCH

NDC Information of Ortho Evra

NDC Code 50458-192-15
Proprietary Name Ortho Evra
Package Description 3 PATCH in 1 CARTON (50458-192-15) > 7 d in 1 PATCH
Product NDC 50458-192
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name norelgestromin and ethinyl estradiol
Dosage Form Name PATCH, EXTENDED RELEASE
Route Name TRANSDERMAL
Start Marketing Date 20011120
Marketing Category Name NDA
Labeler Name Janssen Pharmaceutical, Inc.
Substance Name ETHINYL ESTRADIOL; NORELGESTROMIN
Strength Number .75; 6
Strength Unit mg/7d; mg/7d
Pharmaceutical Classes Progesterone Congeners [Chemical/Ingredient],Progestin [EPC],Estrogen [EPC],Estrogen Receptor Agonists [MoA]

Complete Information of Ortho Evra


General Information